drugset / Trial / NCT03293017
Baclofen in Managing Acute Alcohol Withdrawal
RandomizedParallel-groupDouble-blindTreatment
Summary
The study goal is to investigate whether administration of oral baclofen forms an adequate treatment option in the management of acute alcohol withdrawal. The investigators will compare placebo with doses of baclofen 30 and 60 milligram per day (mg/day) in a randomized controlled trial including patients receiving symptom triggered diazepam.
Timeline
- Start
- 2016-02-01
- Primary completion
- 2022-02-01
- Completion
- 2022-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baclofen | Small molecule | 30 mg | Oral |
| Subject | Baclofen | Small molecule | 60 mg | Oral |
| Subject | Diazepam | Small molecule | 10 mg | Oral |